ENSC
Ensysce Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.37
−2.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -9.20x
- Price / sales
- 6.18x
- Price / cash flow
- -0.81x
Enterprise value
- Enterprise value
- $6.4M
- EV / sales
- 5.48x
- EV / EBITDA
- -0.51x
- EV / EBIT
- -0.50x
- Market cap
- $7.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026